ALPHACREST CAPITAL MANAGEMENT LLC – Supernus Pharmaceuticals, Inc. Transaction History
ALPHACREST CAPITAL MANAGEMENT LLC portfolio value:
$2.48M
portfolio value
ALPHACREST CAPITAL MANAGEMENT LLC quarter portfolio value change:
+17.05%
quarter
Supernus Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +48.37% | 23.96K shares | 1.05M | $33.85 | 73.50K |
| Q2 2022 | share | Increase | 0.00% | 49.54K shares | 1.43M | $28.92 | 49.54K |
| Q1 2022 | share | Decrease | -100.00% | -32.45K shares | -947K | $32.32 | 0 |
| Q4 2021 | share | Increase | +7.37% | 2.22K shares | 141K | $30.03 | 32.45K |
| Q3 2021 | share | Increase | +25.36% | 6.11K shares | 63K | $26.67 | 30.23K |
| Q2 2021 | share | Decrease | -4.51% | -1.13K shares | 82K | $30.79 | 24.11K |
| Q1 2021 | share | Increase | +36.32% | 6.72K shares | 195K | $26.18 | 25.25K |
| Q4 2020 | share | Decrease | -31.19% | -8.39K shares | -95K | $25.16 | 18.52K |
| Q3 2020 | share | Increase | 0.00% | 26.92K shares | 561K | $20.84 | 26.92K |
| Q2 2020 | share | Decrease | -100.00% | -37.65K shares | -677K | $23.75 | 0 |
| Q1 2020 | share | Increase | +250.04% | 26.89K shares | 422K | $17.99 | 37.65K |
| Q4 2019 | share | Decrease | -64.96% | -19.94K shares | -589K | $23.72 | 10.75K |
| Q3 2019 | share | Increase | +120.86% | 16.8K shares | 384K | $27.48 | 30.7K |
| Q2 2019 | share | Decrease | -40.60% | -9.5K shares | -360K | $33.09 | 13.9K |
| Q1 2019 | share | Increase | +61.38% | 8.9K shares | 338K | $35.04 | 23.4K |
| Q4 2018 | share | Increase | 0.00% | 14.5K shares | 482K | $33.22 | 14.5K |